Neoss has extended its line of biomaterials with the launch of NeoGenix Extraction Allograft which aims to offer predictable and reliable outcomes, making it a trusted and affordable alternative to traditional xenografts and synthetic products.
Made of 100% human allograft bone fiber and bone particulate is designed to simplify bone regeneration for all types of dental practitioners, offering an effective and streamlined, one-step solution for enhancing patient outcomes.
NeoGenix Extraction Allograft is composed of 100% human allograft, incorporating a precise blend of demineralised bone fibers and mineralized bone particulate.
By combining both cortical and cancellous materials into a convenient plug shape, the allograft creates an optimal environment for stronger and faster bone growth.
This innovative composition eliminates the need for mixing particulate grafts or applying additional membrane, making the process more efficient and less complex for clinicians.
“We are pleased to offer a new allograft fiber for extraction sites that not only delivers cost-effective results but also fosters faster, stronger bone growth. This helps preserve the integrity of the patient’s bone structure, ensuring that practitioners can keep future implant treatment options open, providing patients with a reliable foundation for long-term dental health,” said John Chopack, managing director of Neoss USA.
With its focus on ease of use and clinical effectiveness, NeoGenix Extraction Allograft provides dental professionals with a seamless, one-step solution to support high-quality patient care.
Related: Geistlich receives MDR approval for entire product portfolio
